Example: Heart Attack

Search clinical trials for: machine-learning algorithm

Total 10000 results

NCT01138397

Completed

Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route)

Influenza
NCT00963157

Completed

Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations

Influenza
NCT01001650

Completed

Clinical Trial of the PfSPZ Vaccine

Plasmodium Falciparum
NCT00383539

Completed

Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults

Influenza | Orthomyxoviridae Infection | Myxovirus Infection
NCT00465205

Completed

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons

HIV Infections | Sexually Transmitted Diseases | Herpes Simplex
NCT00003665

Completed

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Melanoma (Skin)
NCT01210742

Unknown

The Efficacy of Viscosupplementation for Early Knee Osteoarthritis (EVOKE)

Knee Osteoarthritis
NCT00170612

Completed

Pneumococcal Vaccination of Fiji Infants

Pneumococcal Infections
NCT00153556

Completed

Study to Eliminate Hib Carriage in Rural Alaska Native Villages

Haemophilus Influenzae Type B | Carrier State
NCT05078866

Active, not recruiting

Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients

Lynch Syndrome | Colorectal Carcinoma
NCT06284876

Recruiting

Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer

Peptic Ulcer
NCT01773928

Completed

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Influenza
NCT02593227

Completed

Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer

Breast Cancer
NCT01406522

Withdrawn

Tacrine Effects on Cocaine Self-Administration and Pharmacokinetics

Cocaine Dependence
NCT00002490

Completed

Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer

Bladder Cancer
NCT03903692

Terminated

A Comparative Evaluation of a MPS Dressing and a CMC Dressing on Subjects With Lower Extremity Venous Ulcers

Venous Leg Ulcer
NCT07216430

Recruiting

Safety and Efficacy of wSp Vaccine in Young Children (wSp005)

Acute Otitis Media (AOM)
NCT06272812

Recruiting

A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic Region.

Tuberculosis (TB)
NCT05332353

Recruiting

Machine Learning-Based Prediction of BCG Response in High-Risk Non-Muscle Invasive Bladder Cancer Patients

Non-Muscle Invasive Bladder Cancer
NCT05171946

Not yet recruiting

Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults

Vaccine Adverse Reaction | Vaccine Reaction | Safety | Immunization; Infection
NCT04865939

Recruiting

Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma

Urothelial Cancer of Renal Pelvis | Urothelial Carcinoma Ureter
NCT07128121

Active, not recruiting

A Phase 2 Study to Describe the Safety and Immunogenicity of Respiratory Syncytial Virus Vaccine IN006 in Healthy Participants Aged 60 Years and Older

Respiratory Syncytial Virus (RSV) Infection
NCT01261728

Completed

Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma

Urothelial Carcinoma
NCT05506969

Completed

Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age

Vaccine-Preventable Diseases | Plague | Plague, Pneumonic
NCT06767982

Completed

Comparison of BCG RIVM and Russian Strains for Treating Non-Muscle-Invasive Bladder Cancer (NMIBC)

Non Muscle Invasive Bladder Cancer
NCT06447779

Active, not recruiting

Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older

Herpes Zoster
NCT02618967

Completed

Single Ascending Dose Study of AMG 570 in Healthy Subjects

Systemic Lupus Erythematosus
NCT01751776

Completed

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy

Healthy | Arthritis, Rheumatoid
NCT05020145

Completed

COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States

Covid-19 | Immunocompromised | Breakthrough Infection | SARS-COV-2 Infection | SARS-COV-2 | Immunosuppressed
NCT05084261

Completed

An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC) (SCOUT)

Ulcerative Colitis
NCT02255227

Terminated

Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD (PneumoMICI)

Bowel Diseases, Inflammatory | Infections, Pneumococcal
NCT01081223

Completed

Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma

Glioma | Glioblastoma Multiforme | High Grade Astrocytoma
NCT03874234

Terminated

Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy Subjects

Leishmaniasis
NCT02707692

Completed

Perturbing of HIV Reservoir With Immune Stimulation

HIV | AIDS
NCT05401305

Completed

Safety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type b

Vaccines | Haemophilus Influenzae Infection
NCT04881396

Completed

Response of Haemodialysis Patients to BNT162b2 mRNA Cov-19 Vaccine (ROMANOV)

Hemodialysis Complication | COVID-19 Vaccines
NCT01964937

Withdrawn

Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults

HIV Infections
NCT05021016

Completed

Study of the EpiVacCorona Vaccine With the Involvement of Volunteers Aged 60 Years and Above

Covid19
NCT03731182

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Children With Sickle Cell Disease (V114-023/PNEU-SICKLE)

Pneumococcal Infections
NCT03950622

Completed

Safety and Immunogenicity of V114 in Healthy Adults (V114-019/PNEU-AGE) (PNEU-AGE)

Pneumococcal Infections
NCT03950856

Completed

Lot-to-Lot Consistency of V114 in Healthy Adults (V114-020) (PNEU-TRUE)

Pneumococcal Infections | Pneumonia, Pneumococcal
NCT03252353

Unknown

Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly (OPTIMAL)

Acromegaly
NCT02514746

Completed

Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose

Encephalitis, Japanese
NCT03175380

Completed

Biological Samples Obtained by Leukapheresis Induced by Two BCG Vaccinations in BCG-naïve Healthy Adults in the US ((A-051))

Tuberculosis
NCT02612909

Completed

A Safety and Immunogenicity Study of IVACFLU-A/H5N1

Avian Influenza
NCT00546078

Completed

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

Infections, Papillomavirus
NCT00958243

Completed

A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population in the USA

Influenza
NCT03525652

Unknown

Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment

Prostate Cancer
NCT01577771

Completed

Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina Faso (PCV13-Bobo)

Pneumococcal Infections
NCT03014076

Completed

Immunotherapy Vaccine and Herceptin in Breast Cancer

Breastcancer

Search clinical trials for: machine-learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations